NecstGen

The Netherlands Center for the Clinical advancement of Cell and Gene Therapies (NecstGen), situated in Leiden, comprises of a state-of-the-art facility and expert knowledge for the development, production, and commercialization of Cell and Gene Therapies. NecstGen helps academic and industrial Cell & Gene Therapy developers to enter the clinical stage by bringing together the required expertise from R&D, development, production, QA, QC and regulatory affairs in a brand new 4,000 m2 development & GMP manufacturing facility.

We enable the next generation of therapies by translating research programs into actionalbe health solutions for patients.

Together with our clients and partners we challenge today’s possibilities and enable the unthinkable. NecstGen primarily enables early-stage research organizations and start-ups with efficient process development and GMP manufacturing. We expect to engage with organizations worldwide in the future. NecstGen is a spin-out of the Leiden University Medical Center. This enables us to not just be a CDMO, but a center of expertise in a unique position.